JPRN-UMIN000003182已完成未知
A prospective investigation of the effect with Lomerizine on visual field damage in eyes with glaucoma - The effect with Lomerizine on visual field damage
niversity of Yamanashi, Depertment of Ophthalmology0 个研究点目标入组 100 人开始时间: 2010年2月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Having history of severe diabetes mellitus and cardiac disease etc. 2. Having administration of calcium channel blocker. 3. Having ocular diseases other than glaucoma. 4. Having history of intraocular surgery and laser surgery within 12 months.
研究者
相似试验
已完成
2 期
A prospective pilot study of the usefulness of l-menthol as antispasmodic drug during ERCP.JPRN-UMIN000029125Teikyo University Mizonokuchi Hospital Department of Gastroenterology100
进行中（未招募）
1 期
An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trialAlzheimer’s Disease and behavioral variant Frontotemporal DementiaMedDRA version: 19.0Level: PTClassification code 10068968Term: Frontotemporal dementiaSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-002013-37-NLTauRx Therapeutics Ltd966
进行中（未招募）
1 期
An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trialAlzheimer’s Disease and behavioral variant Frontotemporal DementiaMedDRA version: 19.0 Level: PT Classification code 10068968 Term: Frontotemporal dementia System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disordersEUCTR2014-002013-37-GBTauRx Therapeutics Ltd966
进行中（未招募）
1 期
An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trialEUCTR2014-002013-37-HRTauRx Therapeutics Ltd966
进行中（未招募）
1 期
An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trialAlzheimer’s Disease and behavioral variant Frontotemporal DementiaMedDRA version: 19.0Level: PTClassification code 10068968Term: Frontotemporal dementiaSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-002013-37-FITauRx Therapeutics Ltd966